The next nanosonics or impedimed, page-12

It's pretty hard to say that ACG target market is 2/3 the size of IPD.

Stiffness is 2/3 the size, but blood pressure being more accurate makes this a less specialised tool also.

it's far more accurate at reading blood pressure than the old method which relies on timing and counting from the nurse/doctor to perform. There is room for this in any clinic worldwide and as it is now more reimbursable for the doctor to own, this will be more and more true.

I agree 60m feels right, but also think this has a larger applicable base than IPD.